Palliative chemotherapy in patients with thrombophilia is a challenge for clinical oncologists. On one hand the optimal treatment should be very safe for patient, on the other hand -as effective as possible. That therapy is also connected with proper thromboprophylaxis. The incidence of multiple cancers is a serious problem of modern oncology. In patients whose medical history includes two or more cancers, it is essential to obtain histopathological diagnosis before the administration of treatment of disseminated disease. It allows to avoid improper therapy which is often toxic. The article presents the case of a patient with antithrombin deficiency and two cancers in medical history: colon cancer and endometrial cancer. The treatment of the patient because of the metastatic cancer was started after the histopathological diagnosis. In metastatic lymph node the endometrial cancer was recognized.
IntroductIon
Thrombophilia is an abnormality of blood coagulation that increases the risk of thrombosis. That prothrombic state can be congenital or acquired condition that tends to cause venous thromboembolism (VTe) [1] . Based on risk level we can divide it into mild and severe coagulopathy.
One of the severe coagulopathies is antithrombine (aT) deficiency, in which heterozygote's risk is 20-50 times higher. There are two types of antithrombine deficiency:
• type I antithrombin deficiency is characterised by a decrease in both antithrombin activity and antithrombin concentration in the blood of affected individuals
• type II antithrombin deficiency is characterised by normal antithrombin levels but reduced antithrombin activity in the blood of affected individuals.
The diagnosis of hypercoagulability itself is not the indication for a treatment but prophylaxis should be taken into consideration.
For example in abdominal surgery or delivery in patients with aT deficiency infusion of antithrombin concentrate may be administered. In patients with thrombophilia and VTe vitamin K antagonists (VKa) are used to treat. In aT deficiency heparins are efficient as well. However, in very low aT level, which we can see in Disseminated Intravascular Syndrome (DIc) the role of heparins is limited. after the first episode of venous thromboembolism patients should be treated with anticoagulants for their whole live [1] .
cAse study
In 2014 69-year-old women was admitted to the Oncology Department in Rybnik with the history of treatment in nearby hospital. capecitabine in monotherapy had been advised because of disseminated cancer -probably disseminated colon cancer.
The history treatment of the patient has been analyzed: the previous advice to administer a capecitabine was questioned. Before implementing the therapy the further diagnostic should be performed. comorbidity of patients was coagulopathy-point mutation of (nt 683g.T), correlated with antithrombin I deficiency [2, 3] . Patient was treated with acenocumarol because of VTe episode in the past. Biopsy of neck lymph node was planned. Before that a switch from acenocumarole to enoxaparin in treatment dose was required [3, 4] . In case of large surgery -such as hemicolectomy -patient received antithrombin concentrate [3] . Histopathological test result presented diagnosis different to the primary one -metastatic endometrial cancer in lymph node. 
dIscussIon
In this case, proper treatment and monitoring of accompanying diseases in palliative treatment was taken into account. chemotherapy in patients with aT deficiency should be conducted with caution [5, 6] . chemotherapy, as well as disseminated neoplasm brings higher thrombosis risk, and should be carefully managed in thrombophilia patients [5, 6] . It is suggested that VTe inducing factors may be endothelial cells activations, and pro coagulative agents released during apoptosis [7] . Knowing the reasons of thrombophilia helps proper management, prophylaxis and treatment. close examinations between the courses can prevent potential complications and drugs interactions with VKa [8] . malnutrition, diarrhoea, vomits can influence vitamin K1 level [9] . adequate control of comorbid can prolong palliative treatment by avoiding serious complications (g3-g4
according to cTc ae) [10] .
concLusIon multiple neoplasms (synchronic and metachronic) are becoming more considerable problems of the modern oncology [11] . The presented case with two cancers in history shows how histopathological confirmations of relapsed disease lead to optimal therapy. every attempt of histopathological test should be undertaken when two cancers are diagnosed before treatment of relapsed disease. It helps to avoid unsuccessful therapy without any benefits but with range of complications.
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